These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7660007)

  • 21. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategies of vaccination for adult population in Spain in the actuality].
    de Miguel AG
    An R Acad Nac Med (Madr); 2006; 123(1):175-94. PubMed ID: 17172219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vaccination perspectives].
    Saliou P; Plotkin S
    Sante; 1994; 4(3):237-41. PubMed ID: 7921696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovative vaccine production technologies: the evolution and value of vaccine production technologies.
    Bae K; Choi J; Jang Y; Ahn S; Hur B
    Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of immune effect of nine kinds of recombinant hepatitis B vaccines made in China and foreign countries.
    Jing Q; Ren L; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):349-51. PubMed ID: 11471023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel vaccine approaches.
    Ertl HC; Xiang Z
    J Immunol; 1996 May; 156(10):3579-82. PubMed ID: 8621889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
    Bejon P; Peshu N; Gilbert SC; Lowe BS; Molyneux CS; Forsdyke J; Lang T; Hill AV; Marsh K
    Clin Infect Dis; 2006 Apr; 42(8):1102-10. PubMed ID: 16575727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
    Davison F; Nair V
    Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress on vaccines against parasites.
    Engers HD; Bergquist R; Modabber F
    Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live bacterial vaccines--a review and identification of potential hazards.
    Detmer A; Glenting J
    Microb Cell Fact; 2006 Jun; 5():23. PubMed ID: 16796731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biotechnology and vaccinations].
    Peret R
    Actual Odontostomatol (Paris); 1990 Dec; (172):663-74. PubMed ID: 2077866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccinations: present and future].
    Hannoun C
    Rev Prat; 1980 Mar; 30(15):981-5. PubMed ID: 6769146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.